You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

auto HSCT

Showing 1 - 25 of 1,489
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oral Mucositis, Lymphoma, Multiple Myeloma Trial in Seoul (MIT-001, normal saline)

Recruiting
  • Oral Mucositis
  • +3 more
  • Seoul, Korea, Republic of
  • +1 more
Aug 9, 2022

Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,

Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital of Sun Yat-sen University
Sep 25, 2023

B-cell Acute Lymphoblastic Leukemia Trial in Suzhou (CD22/CD19 CAR T and auto-HSCT "sandwich" strategy)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • CD22/CD19 CAR T and auto-HSCT "sandwich" strategy
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 20, 2022

Lymphoma, Large B-Cell, Diffuse, Mantle Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Nanjing (Chidamide)

Active, not recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • +3 more
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Dec 30, 2021

Non-Hodgkin's Lymphoma, Plasma Cell Myeloma Trial in Philadelphia (procedure, drug, other)

Completed
  • Non-Hodgkin's Lymphoma
  • Plasma Cell Myeloma
  • Hematopoietic Cell Transplantation
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 16, 2022

Safety and Efficacy Trial in Suzhou (anti-CD19 and anti-BCMA CAR, Immunomodulatory drugs)

Recruiting
  • Safety and Efficacy
  • anti-CD19 and anti-BCMA CAR
  • Immunomodulatory drugs
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
May 17, 2021

Lymphoma, Multiple Myeloma Trial in Minneapolis (CMV-MVA Triplex Vaccine)

Completed
  • Lymphoma
  • Multiple Myeloma
  • CMV-MVA Triplex Vaccine
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Aug 11, 2021

NHL, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis, Saint Louis (FT596, Rituximab)

Suspended
  • NHL
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Jan 31, 2023

Extranodal NK-T-Cell Lymphoma, Nasal Type Trial in Shanghai, Urumqi (MEDA, Auto-HSCT)

Completed
  • Extranodal NK-T-Cell Lymphoma, Nasal Type
  • Shanghai, Shanghai, China
  • +6 more
Apr 24, 2020

Autologous Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Conditioning Trial in Guangzhou (Idarubicin(IDA),

Completed
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Mar 2, 2020

Autologous Hematopoietic Stem Cell Transplantation, Conditioning, Multiple Myeloma Trial in Guangzhou (Busulfan (BU),

Unknown status
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Busulfan (BU)
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Feb 24, 2020

Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

Not yet recruiting
  • Lymphoma
  • Peripheral Blood Stem Cell Transplantation
  • Eltrombopag olamine
  • (no location specified)
Jul 25, 2023

CNS Lymphoma Trial in Shanghai (Orelabrutinib, Rituximab, Chemotherapy)

Not yet recruiting
  • CNS Lymphoma
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 22, 2023

Neuroblastoma Trial in Guangzhou (Anti Thymocyte Globulin, Fludarabine, Cyclophosphamide injection)

Not yet recruiting
  • Neuroblastoma
  • Anti Thymocyte Globulin
  • +10 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 29, 2022

Acute Myeloid Leukemia, MDS, Transplant-Related Hematologic Malignancy Trial in Milano (Fludarabine, ARA-C, Treosulfan)

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Milano, Lombardia, Italy
    Ospedale San Raffaele
Jul 18, 2022

Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

Not yet recruiting
  • COVID-19
  • +2 more
    • Cologne, NRW, Germany
      University Hospital of Cologne
    Oct 27, 2022

    Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

    Active, not recruiting
    • Acute Lymphocytic Leukemia
    • Lymphoma
    • Biological/Genetically Modified T cells
    • Cyclophosphamide-based chemotherapy
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 3, 2023

    Allogeneic Hematopoietic Stem Cell Trial in New York (fecal microbiota transplantation (FMT), No fecal microbiota

    Active, not recruiting
    • Allogeneic Hematopoietic Stem Cell
    • fecal microbiota transplantation (FMT)
    • No fecal microbiota transplantation (FMT), routine management
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 25, 2022

    Leukemia, Lymphocytic, Acute, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell Trial in Shenzhen (CART19 cell

    Unknown status
    • Leukemia, Lymphocytic, Acute, B-Cell
    • +2 more
    • CART19 cell and auto-HSCT
    • Shenzhen, Guangdong, China
      Weihong Chen
    Dec 5, 2018

    Primary CNS Lymphoma Trial in Moscow (Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide)

    Recruiting
    • Primary CNS Lymphoma
    • Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide
    • Moscow, Russian Federation
      Nathional Medical Research Center for Hematology
    Jun 16, 2022

    Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Salt Lake City (TAA-T cells, Nivolumab)

    Recruiting
    • Hodgkin Lymphoma
    • Diffuse Large B Cell Lymphoma
    • Salt Lake City, Utah
    • +1 more
    Jul 14, 2021

    ALK-Positive Anaplastic Large Cell Lymphoma Trial in Zhengzhou (Crizotinib, Etoposide Capsule, Auto-HSCT)

    Unknown status
    • ALK-Positive Anaplastic Large Cell Lymphoma
    • Zhengzhou, Henan, China
      Oncology Department of The First Affiliated Hospital of Zhengzho
    Oct 12, 2018

    Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult Trial in Leon (Brentuximab Vedotin 50 MG

    Recruiting
    • Hodgkin Lymphoma
    • +2 more
    • Brentuximab Vedotin 50 MG [Adcetris]
    • Leon, Guanajuato, Mexico
      Hospital Regional Alta Especialidad Bajio
    Oct 24, 2022

    Acute Leukemia in Remission, MDS, Myeloproliferative Syndrome Trial (Fecal Microbiota Transplantation)

    Not yet recruiting
    • Acute Leukemia in Remission
    • +6 more
    • Fecal Microbiota Transplantation
    • Amiens, France
    • +19 more
    Oct 18, 2022

    Blood Pressure, Hypertension, Cancer Trial in Durham (Automated Messaging)

    Suspended
    • Blood Pressure
    • +6 more
    • Automated Messaging
    • Durham, North Carolina
      Duke University Medical Center
    Jan 21, 2022